LNKMutations inJAK2Mutation–Negative Erythrocytosis

Authors:
  • TLTerra L. Lasho
    Terra L. Lasho
  • APAnimesh Pardanani
    Animesh Pardanani
  • ATAyalew Tefferi
    Ayalew Tefferi

Abstract
Erythrocytosis occurring in association with a subnormal serum erythropoietin level is indicative of underlying erythropoietin-independent erythropoiesis, in patients with polycythemia vera, or erythropoietin-hypersensitive erythropoiesis, in patients with congenital erythrocytosis related to an erythropoietin-receptor mutation.1 Activating Janus kinase 2 (JAK2) mutations are found in approximately 99% of patients with polycythemia vera.2 It is currently assumed that other mutations relevant to JAK signaling contribute to the pathogenesis of JAK2 mutation–negative polycythemia vera or “idiopathic erythrocytosis” in patients with a subnormal serum erythropoietin level.